Unichem Labs receives USFDA nod on aripiprazole pills

Unichem Labs receives USFDA nod on aripiprazole pills

by admin- Thursday, July 1st, 2021 03:51:37 PM

Unichem Laboratories received tentative acclaim for ANDA of Aripiprazole Tablets, USP, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg and 30 mg from the United States Food and Drug Administration (USFDA) for a widely wide-spread version of ABILIFY (Aripiprazole Tablets) 2 mg, five mg, 10 mg, 15 mg, 20 mg and 30 mg of Otsuka Pharmaceutical Co Ltd.

Aripiprazole Tablets are indicated for Schizophrenia, Irritability Associated with Autistic Disorder and remedy of Tourette’s sickness. Product will be commercialized from Unichem’s Ghaziabad Plant on receipt of full approval.

News Updates